Patent Assignment
Reel/Frame 064948/0747
Assignment of Assignor's Interest
Recorded: 2023-09-19
Pages: 6
Assignor
CELLULAR BIOMEDICINE GROUP HK LTD.
Executed: 2023-09-13
Assignee
CELLULAR BIOMEDICINE GROUP, INC.
9605 MEDICAL CENTER DRIVE, SUITE 100, ROCKVILLE, MARYLAND, 20850
Covered Properties
(3)
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
Application:
63/154,032 →
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application:
63/142,216 →
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application:
63/154,040 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 3, 2021
From: YAO, YIHONG; HUANG, JIAQI; YAO, XIN
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 055481/0253 →
Assignment of Assignor's Interest
Mar 3, 2021
From: YAO, YIHONG; HUANG, JIAQI; YAO, XIN
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 055481/0160 →
Assignment of Assignor's Interest
Mar 29, 2021
From: YAO, YIHONG; HUANG, JIAQI; YAO, XIN
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 055754/0001 →
Assignment of Assignor's Interest
Apr 1, 2022
From: ZHU, SHIGUI
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 059474/0308 →
Change of Name
Jan 19, 2024
From: CELLULAR BIOMEDICINE GROUP, INC.
To: ABELZETA INC.
Reel/Frame 066356/0108 →